Immunovant, Inc. (IMVT) Estimates

Detailed analyst consensus, revenue, and earnings forecasts vs reported data.

Revenue Estimates

Metric Q3 23Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26
Reported (Actual) 0.000.000.000.000.000.000.000.00----
High Estimate 0.000.000.000.000.000.000.000.000.000.000.000.00
Low Estimate 0.000.000.000.000.000.000.000.000.000.000.000.00
Consensus Estimate 0.000.000.000.000.000.000.000.000.000.000.000.00

Earnings Per Share (EPS) Estimates

Metric Q3 23Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26
Reported (Actual) -0.29-0.52-0.60-0.74-0.76-0.64-0.71-0.73----
High Estimate -0.44-0.45-0.58-0.65-0.76-0.80-0.68-0.70-0.75-0.83-0.80-0.74
Low Estimate -0.40-0.37-0.54-0.59-0.68-0.66-0.60-0.62-0.63-0.71-0.74-0.68
Consensus Estimate -0.42-0.41-0.56-0.62-0.72-0.73-0.64-0.66-0.69-0.77-0.77-0.71